Table 2.
Association between 25 and 50 mg dose of rectal diclofenac and post-ERCP pancreatitis
| OR | (95% CI) | p Value | |
|---|---|---|---|
| Post-ERCP pancreatitis | |||
| Univariate | 0.37 | (0.17 to 0.80) | 0.018 |
| Multivariate | |||
| Model 1 | 0.31 | (0.13 to 0.75) | 0.009 |
| Model 2 | 0.27 | (0.11 to 0.70) | 0.007 |
ORs were calculated for the 50 mg group referring to the 25 mg group.
Model 1: Adjusted for sex, age and BMI.
Model 2: Adjusted for sex, age, BMI, type of operator, difficult cannulation and procedures for pancreatic duct.
BMI, body mass index; ERCP, endoscopic retrograde cholangiopancreatography.